The Effect of Atrial Fibrillation Hemodynamics on Regulation of Cerebral Blood Flow
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Atrial Fibrillation
Related studies linked through entity extraction aliases.
Atrial Fibrillation Ablation Pilot Study
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
- Status
- TERMINATED
- Phase
- PHASE3
A(f)MAZE-CABG Study
- Status
- TERMINATED
- Phase
- NA
SOLAR & ATRILAZE Atrial Fibrillation Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Genomic Investigation of Cardiovascular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Ongoing WARfarin and Coronary STENTing
- Status
- UNKNOWN
- Phase
- N/A
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
- Status
- TERMINATED
- Phase
- PHASE3
Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
- Status
- COMPLETED
- Phase
- NA
Safety Study of Tecadenoson to Treat Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE2
An Interaction Study With Digoxin and AZD1305
- Status
- COMPLETED
- Phase
- PHASE1
Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) Patients
- Status
- TERMINATED
- Phase
- NA
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
- Status
- COMPLETED
- Phase
- PHASE4
Implantable Loop Recorder Versus Conventional Ambulatory Monitoring in Detecting Atrial Fibrillation After Pulmonary Vein Isolation
- Status
- COMPLETED
- Phase
- NA
European Study of Dronedarone in Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Spironolactone for Paroxysmal Atrial Fibrillation
- Status
- UNKNOWN
- Phase
- NA
Reveal® XT Performance Trial (XPECT)
- Status
- COMPLETED
- Phase
- PHASE4